GE HealthCare Technologies Inc.FDA clearance for AI-powered radiation therapy planning software enhances product offering and efficiency.

GE HealthCare received FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, an AI-powered software designed to streamline radiation therapy planning. The clearance includes a Predetermined Change Control Plan that creates a framework for introducing future enhancements and new anatomical models more efficiently. The update introduces an MR Brain model and an improved CT Male Pelvis model to assist oncology teams in delivering more personalized patient care. The software automates the time-intensive process of manual contouring, helping clinicians increase efficiency while maintaining high accuracy, and operates with minimal user interaction by automatically initiating contouring and integrating directly with existing treatment planning systems.
GE HealthCare Technologies Inc.FDA clearance for AI-powered radiation therapy planning software enhances product offering and efficiency.